NDC 59212-242
LANOXIN
Digoxin
LANOXIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Digoxin.
| Product ID | 59212-242_02e7f36a-77da-42f4-a7b1-634664347b7f |
| NDC | 59212-242 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LANOXIN |
| Generic Name | Digoxin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-09-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020405 |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Substance Name | DIGOXIN |
| Active Ingredient Strength | 0 mg/1 |
| Pharm Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 59212-242-55
100 TABLET in 1 BOTTLE (59212-242-55)
| Marketing Start Date | 2012-09-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 59212-242-56 [59212024256]
LANOXIN TABLET
| Marketing Category | NDA |
| Application Number | NDA020405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-09-30 |
NDC 59212-242-76 [59212024276]
LANOXIN TABLET
| Marketing Category | NDA |
| Application Number | NDA020405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-09-30 |
| Marketing End Date | 2019-03-05 |
NDC 59212-242-55 [59212024255]
LANOXIN TABLET
| Marketing Category | NDA |
| Application Number | NDA020405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-09-30 |
NDC 59212-242-75 [59212024275]
LANOXIN TABLET
| Marketing Category | NDA |
| Application Number | NDA020405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-09-30 |
| Marketing End Date | 2015-08-31 |
NDC 59212-242-57 [59212024257]
LANOXIN TABLET
| Marketing Category | NDA |
| Application Number | NDA020405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-09-30 |
| Marketing End Date | 2019-03-05 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| DIGOXIN | .125 mg/1 |
OpenFDA Data
| SPL SET ID: | d91e3646-4c63-4512-ab22-db39c085c4dc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Cardiac Glycoside [EPC]
- Cardiac Glycosides [CS]
Medicade Reported Pricing
59212024256 LANOXIN 125 MCG TABLET
Pricing Unit: EA | Drug Type:
59212024255 LANOXIN 125 MCG TABLET
Pricing Unit: EA | Drug Type:
NDC Crossover Matching brand name "LANOXIN" or generic name "Digoxin"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70515-260 | LANOXIN | LANOXIN |
| 70515-262 | LANOXIN | LANOXIN |
| 71610-019 | LANOXIN | LANOXIN |
| 55154-6726 | LANOXIN | LANOXIN |
| 59212-240 | LANOXIN | LANOXIN |
| 59212-245 | LANOXIN | LANOXIN |
| 59212-242 | LANOXIN | LANOXIN |
| 59212-249 | LANOXIN | LANOXIN |
| 65084-455 | LANOXIN | LANOXIN |
| 70515-261 | LANOXIN | LANOXIN |
| 70515-263 | LANOXIN | LANOXIN |
| 0378-6155 | DIGITEK | digoxin |
| 0378-6156 | DIGITEK | digoxin |
| 0527-1324 | DIGOX | Digoxin |
| 0527-1325 | DIGOX | Digoxin |
| 0054-0057 | Digoxin | Digoxin |
| 0115-9811 | Digoxin | DIGOXIN |
| 0115-9822 | Digoxin | DIGOXIN |
| 0143-1240 | Digoxin | Digoxin |
| 0143-1241 | Digoxin | Digoxin |
| 0404-9850 | Digoxin | Digoxin |
| 0615-0518 | Digoxin | Digoxin |
| 0615-0547 | Digoxin | Digoxin |
| 0615-7729 | Digoxin | Digoxin |
| 0615-7730 | Digoxin | Digoxin |
| 0615-7935 | DIGOXIN | DIGOXIN |
| 0615-8202 | Digoxin | Digoxin |
| 0641-1410 | Digoxin | Digoxin |
| 0641-6184 | Digoxin | Digoxin |
| 0781-3059 | Digoxin | Digoxin |
| 0904-5921 | Digoxin | Digoxin |
Trademark Results [LANOXIN]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LANOXIN 72005389 0638717 Live/Registered |
BURROUGHS WELLCOME & CO. (U. S. A.) INC. 1956-03-29 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.